1
Oct
2015

Adv. Einat Weidberg, represented Novocure (NASDAQ: NVCR), an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, as Israeli counsels, in the IPO of Novocure securities on NASDAQ.

click here for further reading

Print Friendly, PDF & Email